Another study is testing how CagriSema works over longer periods and in people with higher body weights, with results expected around the first half of 2027
For gastric conditions (ulcers, gastritis, mucosal erosion), administering on an empty stomach or 30 minutes before meals maximizes contact with the gastric lining
If you struggle with body fat, have health issues related to obesity, or have not found success with traditional weight loss methods, you might benefit from weight loss peptides and peptides for fat loss
Although cagrilintide-semaglutide produced greater weight loss than either monotherapy alone in REDEFINE 1, the study design does not permit a formal assessment of pharmacological additivity or synergy
Many patients report significant energy improvements within just the first few weeks of treatment
This means that you receive all of the potential benefits of the medicineand it also means youll enjoy quicker results